Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Supply chain

Pharmacist and drug associations want better data on medicine shortages

pharmacist looking for medicine


Updating information about medicines shortages would facilitate the work of pharmacists and prevent treatment interruptions for patients

European bodies representing pharmacists, drug manufacturers and distributors have issued recommendations on how data on medicines shortages could be better used to mitigate the impact on patients. 

“There is no universally accepted definition of a medicine shortage in Europe,” the associations point out, going on to call for an approach in which suspected shortages are flagged, regardless of whether they are already in short supply or apply to single or multi-source products.

The organisations also say that making more up-to-date information about medicines shortages available will improve the ability of health systems to solve supply issues as they arise. This would enable existing stocks to be better managed and distributed and contingency measures deployed, which may involve urgent communication to prescribers, pharmacies and wholesalers and preparation of bespoke out-of-license or magisterial products, to minimise the impact to patient care, they add.

The recommendations were issued in a joint statement from the Association of the European Self-Medication Industry, the European Association of Euro-Pharmaceutical Companies, the European Association of Hospital Pharmacists, the European Industrial Pharmacists Group, the European Federation of Pharmaceutical Industries and Associations, the European Healthcare Distribution Association, Medicines for Europe and the Pharmaceutical Group of the European Union.

The recommendations also say that drug firms are obliged to report potential supply disruption owing to manufacturing/quality issues to the authorities, but information systems should be open to reports from wholesalers, parallel traders, pharmacists and other healthcare professionals.

“Signals of medicine shortages” can then be periodically assessed by a panel of supply chain members to establish if they are suspected or actual shortages, the statement says, adding that access to information on verified shortages should be generally made available to the public, and patient organisations can have a useful role in supporting patients with information and advice.

If the medicine suspected to be in shortage has an alternative (for example, generic substitute or product with same ingredient), the unavailability could still be reported as a suspected shortage, because “wholesalers are not allowed to substitute orders and, in some cases, pharmacists require proof of a shortage in order to enable substitution”.

“This could facilitate the work of pharmacists in finding the appropriate replacement therapy or action, and treatment of patients will not be interrupted,” the statement adds. “Pharmacists, with their knowledge of medicines and products, may be in position to offer training or support to other professionals on the correct selection and use of substituted products.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202291

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £520.00Buy now
  • Martindale: The Complete Drug Reference

    Martindale: The Complete Drug Reference

    Martindale: The Complete Drug Reference provides reliable, unbiased and evaluated information on drugs and medicines used throughout the world.

    £550.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £42.00Buy now
  • FASTtrack: Chemistry of Drugs

    FASTtrack: Chemistry of Drugs

    An accessible introduction to the key aspects of organic chemistry, elementary medicinal chemistry, and biochemistry.

    £24.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £52.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £37.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • pharmacist looking for medicine

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.